Clinical expertise

Dr Vasileios Panoulas has clinical expertise that encompasses both general and interventional cardiology, he is also the interventional lead at Harefield Hospital.

He has a special interest in:

He is currently the interventional lead at Harefield Hospital and has performed over 2000 complex angioplasties and over 800 TAVI procedures. He is a proctor for both TAVI and the percutaneous mechanical assist device, Impella.

His clinical expertise is supported by professional qualifications, including:

  • certification in adult transthoracic echocardiography (from the European Association of Cardiovascular Imaging)
  • computed tomography level two accreditation (from the British Society of Cardiovascular Imaging)


Dr Vasileios Panoulas is a consultant interventional cardiologist and the interventional lead at Harefield Hospital.

From 2008-10, he underwent his core medical training at Guy’s and St Thomas’ Hospital. This was followed by his cardiology core training at Hammersmith Hospital where he was appointed as a National Heart and Lung Institute academic clinical fellow (2010-13).

He then undertook an interventional cardiology fellowship at San Raffaele Scientific Institute, Milan, Italy for a year (2013-14). He completed his MSc in interventional cardiology from Universita Vita-Salute San Raffaele, Milan, Italy.

Subsequently, he returned to London and was a North West London interventional fellow for two years at Hammersmith Hospital (2014-16). At this time, Dr Panoulas was an NIHR clinical lecturer in cardiology at the National Heart and Lung Institute, Imperial College London. He continues his academic work there now as an honorary senior clinical lecturer. Dr Panoulas has been a consultant cardiologist at Royal Brompton and Harefield hospitals since August 2016.


Dr Vasileios Panoulas’s research interests cover:


Dr Vasileios Panoulas has publications covering various topics including:

  • cardiogenic shock; Dr Panoulas has written several articles on risk stratification of patients in cardiogenic shock and use of mechanical support; he has been UK Principal Investigator for the very impactful DANGER shock trial that has been published in NEJM
  • TAVI ; he has written papers on outcomes from different types of valves and use of mechanical support in patients with poor left ventricular ejection fraction
  • complex PCI
  • bioresorbable scaffolds
  • cardiovascular disease in autoimmune diseases
  • genetics of hypertension

He has over 220 peer-reviewed publications and his work has been cited over 9,200 times in global literature.